VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog
← Pulse/Companies/Compare
Celea Therapeutics
VS
Colossal Biosciences

Biotech comparison — funding, valuation, and investors, sourced from Value Add Pulse coverage.

CT
Celea Therapeutics

Clinical-stage biotech developing deupirfenidone, a deuterated pirfenidone-derived drug for idiopathic pulmonary fibrosis, spun out of PureTech Health.

4 Pulse stories
CB
Colossal Biosciences

Colossal Biosciences is a genetic engineering company working to de-extinct species like the woolly mammoth and dire wolf while commercializing spinout biotech applications.

2 Pulse stories
Total Raised
$180M
$850M
Celea TherapeuticsColossal Biosciences
Last Valuation
$10.3B
Celea TherapeuticsColossal Biosciences
Biotech
Sector
Biotech
2025
Founded
2021
Boston, MA
HQ
Dallas, Texas
Private
Status
Private
Celea Therapeutics investors
RA Capital ManagementLeaps by BayerPureTech Health
Colossal Biosciences investors
TWG GlobalThomas TullMark WalterTim DraperWinklevoss CapitalIn-Q-TelARCH Venture PartnersTom Brady

Data from Value Add Pulse coverage and company research — see the full threads for Celea Therapeutics and Colossal Biosciences.

@Trace_Cohen·t@nyvp.com